A phase III registration trial of venetoclax in patients with acute myeloid leukemia

Trial Profile

A phase III registration trial of venetoclax in patients with acute myeloid leukemia

Planning
Phase of Trial: Phase III

Latest Information Update: 29 Jul 2016

At a glance

  • Drugs Venetoclax (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Registrational; Therapeutic Use
  • Sponsors AbbVie
  • Most Recent Events

    • 29 Jul 2016 According to an AbbVie media release, the company plans to start this trial by the end of 2016.
    • 03 Feb 2016 New trial record
    • 29 Jan 2016 The company plans to initiate this trial in 2016, according to an AbbVie media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top